Skip to Content
New To Chronic Myeloid Leukemia? Get Information Today >>

Danaparoid Pregnancy and Breastfeeding Warnings

Danaparoid is also known as: Orgaran

Danaparoid Pregnancy Warnings

One study reports on 2 successful full-term pregnancies with normal infants at birth. Cord blood from the infants revealed no anti-Xa activity, although the mothers demonstrated considerable activity. No bleeding problems were encountered. It does not appear that danaparoid crosses the placenta during the second and third trimesters. Successful danaparoid treatment of heparin-induced thrombocytopenia was reported in a 25-year-old woman pregnant with twins. She was treated with subcutaneous danaparoid until the time of delivery without adverse fetal or maternal effects.

Danaparoid has been assigned to pregnancy category B by the FDA. Animal studies at doses 6 to 8 times the normal recommended human dose have not revealed evidence of fetotoxicity. There are no controlled data in human pregnancy. Danaparoid should only be given during pregnancy when need has been clearly established.

See references

Danaparoid Breastfeeding Warnings

There are no data on the excretion of danaparoid into human milk.

See references

References for pregnancy information

  1. "Product Information. Orgaran (danaparoid)." Organon, West Orange, NJ.
  2. Gill J, Kovacs MJ "Successful use of danaparoid in treatment of heparin-induced thrombocytopenia during twin pregnancy." Obstet Gynecol 90(4 Pt 2) (1997): 648-50
  3. Magnani HN "Heparin-induced thrombocytopenia (HIT): an overview of 230 patients treated with orgaran (Org 10172) [published erratum appears in Thromb Haemost 1993 Dec 20;70(6):1072]." Thromb Haemost 70 (1993): 554-61

References for breastfeeding information

  1. "Product Information. Orgaran (danaparoid)." Organon, West Orange, NJ.

Disclaimer: Every effort has been made to ensure that the information provided by Cerner Multum, Wolters Kluwer Health and is accurate, up-to-date and complete, but no guarantee is made to that effect. In addition, the drug information contained herein may be time sensitive and should not be utilized as a reference resource beyond the date hereof. This material does not endorse drugs, diagnose patients, or recommend therapy. This drug information is a reference resource designed as supplement to, and not a substitute for, the expertise, skill , knowledge, and judgement of healthcare practitioners in patient care. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate that the drug or combination is safe, effective, or appropriate for any given patient. Multum Information Services, Inc. does not assume any responsibility for any aspect of healthcare administered with the aid of information Multum provides. Copyright 2000-2008 Multum Information Services, Inc. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse, or pharmacist.